SEC Form 4 insider trading filings tracked in real time from EDGAR

Hoyos Rocio Martin — Chief Strategy Officer

Insider trading activity for Hoyos Rocio Martin sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Strategy Officer
  • Company: Atrium Therapeutics, Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Apr 22, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 20, 2026 Hoyos Rocio Martin RNA Atrium Therapeutics, Inc. BUY 60,000 N/A
Apr 20, 2026 Hoyos Rocio Martin RNA Atrium Therapeutics, Inc. BUY 30,000 N/A

← All executives · Full trades feed